Development and Validation of an Anxiety Disorder Prediction Model for Premature Ejaculation Patients

Launched by XIJING HOSPITAL · Nov 5, 2024

Keywords

ClinConnect Summary

This clinical trial is focused on understanding how to predict anxiety disorders in men who experience premature ejaculation (PE). PE is a common issue that can affect not just sexual health but also emotional well-being. The goal of this study is to create a model that can identify which patients are at higher risk of developing anxiety related to their condition. By recognizing these individuals early, healthcare providers can offer better support and treatment options.

To participate in the trial, men aged 65 to 74 who have been diagnosed with PE and meet certain criteria can enroll. This includes being in a stable, monogamous relationship and not having severe erectile dysfunction. Participants will complete questionnaires and have interviews to help gather information on their mental health. Throughout the study, researchers will analyze this information to refine the prediction model. Those who take part will help improve care for future patients dealing with similar challenges, making it an important step towards better understanding the link between sexual health and anxiety.

Gender

MALE

Eligibility criteria

• Inclusion Criteria:
• • Comply with the international medical premature ejaculation diagnostic criteria
• • Individuals with a "heterosexual" orientation who engage in vaginal intercourse
• • Having a stable relationship with "monogamy"
• • The International Index of Erectile Function-5 scale is ≥17 points, indicating that the patient has no erectile dysfunction or only mild erectile dysfunction
• • Be informed of the purpose of this study, support this study, and complete the informed consent form
• Exclusion Criteria:
• • Minors under the age of 18
• • Individuals with a sexual orientation of "gay" or "bisexual"
• • The judgment of "ejaculation too fast" is based only on masturbation or non-vaginal sexual intercourse
• • The score of the premature ejaculation self-assessment scale is ≤8 points
• • Suffering from diseases that may affect anxiety symptoms (hyperthyroidism/hypothyroidism, digestive diseases, malignant tumors, etc.)
• • Within 2 months, have taken anti-anxiety drugs and/or drugs for PE treatment
• • Those with a history of severe neurological diseases (such as epilepsy) and/or a history of schizophrenia, bipolar disorder, or other mental disorders
• • Poor cooperation during diagnostic interviews